AI & Markets

Latest in AI & Markets· Oct 22

Wall Street is misreading isolated operational stress at CoreWeave as a sector-wide indictment of AI infrastructure demand, which remains robust across the market. Meta's AI capex has swung the company from cash-generative to cash-consumptive, forcing investors to reassess returns on the buildout against near-term shareholder obligations and debt service. Moderna's shares fell despite positive vaccine efficacy data, signaling investor concern over data governance and competitive timing rather than clinical merit. Nvidia's CEO reports demand for AI infrastructure outpaces available capital, creating a deployment bottleneck that will slow cloud expansion if funding constraints persist.